Safety and Efficacy Evaluation of CO2 Removal in Combination With Continuous Veno-Venous Hemodialysis/Hemodiafiltration Therapy
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Acute Kidney Injury
- Acute Lung Injury
- COVID-19
- Hypercapnia
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: Prospective, non-comparative, multi-centre, open-label, interventional PMCF studyMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04871893
- Collaborators
- CERES GmbH
- Investigators
- Study Director: Thomas Müller, Prof. Dr. Universitätsklinikum Regensburg, Klinik und Poliklinik für Innere Medizin Principal Investigator: Matthias Lubnow, Dr. med. Universitätsklinikum Regensburg, Klinik und Poliklinik für Innere Medizin
Get Well Soon